Loading resource…

American Diabetes Association
Published by the American Diabetes Association, this supplement outlines comprehensive guidance for type 1 and type 2 diabetes, including glycemic targets, hypoglycemia prevention, and use of SGLT2 inhibitors. It includes specific sections on liver disease associated with diabetes, such as MASLD/MASH, and recommendations for screening and treatment. The document also addresses glucagon administration, diabetic ketoacidosis management, and strategies for patient education and monitoring. It is intended for health professionals caring for patients with diabetes across the care continuum.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology

Kiruddu DKA guidelines
Same clinical topic · Endocrinology

Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology

Management of DKA
Same clinical topic · Endocrinology

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT ALGORITHM FOR MANAGEMENT OF ADULTS WITH TYPE 2 DIABETES — 2026 UPDATE
Same clinical topic · Endocrinology

GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CONGENITAL HYPOTHYROIDISM
Same clinical topic · Endocrinology

2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology

CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINE: PHARMACOTHERAPY FOR OBESITY MANAGEMENT IN ADULTS
Same clinical topic · Endocrinology

Nutritional Management of Diabetes SOP (2)
Same clinical topic · Endocrinology